BioSpace.com
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel

Status: 301 Moved Permanently Location: http://www.marketwire.com/press-release/Ablynxs-Anti-IL-6R-Nanobody-ALX-0061-Shows-Excellent-24-Week-Safety-Efficacy-Results-NYSE-ABLX-1756060.htm